A new FDA-approved
CDx for NSCLC
Know EARLY
the PD-L1 status for NSCLC patients with the VENTANA PD-L1 (SP263) Assay
Download the free
VENTANA PD-L1 (SP263) Interpretation Guide
to aid in clinical evaluation and scoring with this new assay.
All fields required
Please connect me with a member of Medical and Scientific Affairs:
Privacy Notice